These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1407723)

  • 1. Localisation of striatal muscarinic receptors involved in dopamine receptor-mediated behavioural responses.
    Crocker AD; Cameron DL
    Neurosci Lett; 1992 Aug; 142(1):73-6. PubMed ID: 1407723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
    Cameron DL; Crocker AD
    Neuroscience; 1989; 32(3):769-78. PubMed ID: 2601845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface?
    Joseph JA; Dalton TK; Roth GS; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):149-55. PubMed ID: 3136856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
    Joseph JA; Dalton TK; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Facilitation of a stereotyped motor behavior (climbing behavior) by previous stimulation of dopaminergic receptors: hyposensitivity of autoreceptors?].
    Costentin J; Marçais H; Protais P; Baudry M; Martres MP; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(2):143-6. PubMed ID: 402241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats.
    Wang JQ; McGinty JF
    Brain Res; 1997 Feb; 748(1-2):62-70. PubMed ID: 9067445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with an irreversible muscarinic agonist affects responses to apomorphine.
    Crocker AD; Russell RW
    Pharmacol Biochem Behav; 1990 Mar; 35(3):511-6. PubMed ID: 2339142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A permanent dopamine receptor up-regulation in the ovariectomized rat.
    Gordon JH; Fields JZ
    Pharmacol Biochem Behav; 1989 May; 33(1):123-5. PubMed ID: 2780771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
    Alcock SJ; Hemsley KM; Crocker AD
    Eur J Pharmacol; 2001 Jul; 424(3):179-87. PubMed ID: 11672560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
    Bevan P
    Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fetal striatal and astrocyte transplants into unilateral excitotoxin-lesioned striatum.
    Lu SY; Pixley SK; Emerich DF; Lehman MN; Norman AB
    J Neural Transplant Plast; 1993; 4(4):279-87. PubMed ID: 7524691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R; Spina L; Di Chiara G
    Life Sci; 1987 Nov; 41(18):2135-45. PubMed ID: 2959833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL; Crocker AD
    Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.